Equity (Details) - USD ($) shares in Millions, $ in Millions |
6 Months Ended | |||
---|---|---|---|---|
Aug. 11, 2023 |
Aug. 31, 2020 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Equity [Line Items] | ||||
Issuance and sale of stock | $ 500.0 | |||
Gross proceed | $ 25.2 | $ 10.9 | ||
Net proceed from issuance of common stock | $ 24.7 | |||
Net proceeds from Issuance of Common Stock | 10.6 | |||
Restricted Stock Units [Member] | ||||
Equity [Line Items] | ||||
Weighted average term | 1 year 2 months 12 days | |||
Compensation expense | $ 0.3 | 0.3 | ||
Fair value of RSU | $ 1.8 | |||
Vesting period | 3 years | |||
Unrecognized compensation | $ 0.7 | |||
Stock Options [Member] | ||||
Equity [Line Items] | ||||
Unrecognized compensation expense | $ 11.9 | |||
Weighted average term | 3 years | |||
Compensation expense | $ 2.4 | $ 1.7 | ||
Capital on Demand Sales Agreement [Member] | ||||
Equity [Line Items] | ||||
Aggregate value of common stock | $ 200.0 | |||
Common Stock [Member] | ||||
Equity [Line Items] | ||||
Aggregate value of common stock | $ 200.0 | |||
Shares of common stock (in Shares) | 2.9 | 1.3 |
X | ||||||||||
- Definition Net proceed from issuance of common stock. No definition available.
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. No definition available.
|
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of cash inflow from the issuance of equity classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Value of preferred stock and warrants for common stock issued. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|